These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
910 related items for PubMed ID: 20693798
1. Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii. Garza-González E, Llaca-Díaz JM, Bosques-Padilla FJ, González GM. Chemotherapy; 2010; 56(4):275-9. PubMed ID: 20693798 [Abstract] [Full Text] [Related]
2. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study. McCracken M, Mataseje LF, Loo V, Walkty A, Adam HJ, Hoban DJ, Zhanel GG, Mulvey MR, Canadian Antimicrobial Resistance Alliance (CARA). Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962 [Abstract] [Full Text] [Related]
3. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO. Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [Abstract] [Full Text] [Related]
4. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics]. Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H. Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430 [Abstract] [Full Text] [Related]
7. Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran: 2006-2009. Mohammadtaheri Z, Pourpaki M, Mohammadi F, Namdar R, Masjedi MR. Chemotherapy; 2010 Apr; 56(6):478-84. PubMed ID: 21099220 [Abstract] [Full Text] [Related]
8. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan. Liu JW, Wang LS, Cheng YJ, Hsu GJ, Lu PL, Liu YC, Chen CM, Lee CM, Sun W, Jang TN, Chiang PC, Chuang YC, Lin HC, Shi ZY, Kung HC, Huang CH, Tsao SM, Lu CT, Liao CH, Hsueh PR. Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353 [Abstract] [Full Text] [Related]
9. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09. Davies TA, Marie Queenan A, Morrow BJ, Shang W, Amsler K, He W, Lynch AS, Pillar C, Flamm RK. J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338 [Abstract] [Full Text] [Related]
10. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Zavascki AP, Carvalhaes CG, Picão RC, Gales AC. Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903 [Abstract] [Full Text] [Related]
11. In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt. Mohamed NM, Youssef AA. Microb Drug Resist; 2011 Dec; 17(4):489-95. PubMed ID: 21875338 [Abstract] [Full Text] [Related]
14. Antimicrobial susceptibility of extended-spectrum beta-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial. Hoban DJ, Bouchillon SK, Dowzicky MJ. Diagn Microbiol Infect Dis; 2007 Apr; 57(4):423-8. PubMed ID: 17403448 [Abstract] [Full Text] [Related]
15. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)]. Zarakolu P, Hasçelik G, Unal S. Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842 [Abstract] [Full Text] [Related]
16. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009]. Hamouche E, Sarkis DK. Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212 [Abstract] [Full Text] [Related]
17. Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline. Somily AM, Absar MM, Arshad MZ, Al Aska AI, Shakoor ZA, Fatani AJ, Siddiqui YM, Murray TS. Saudi Med J; 2012 Jul; 33(7):750-5. PubMed ID: 22821309 [Abstract] [Full Text] [Related]
18. Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline evaluation and surveillance trial, 2004-2009. Namdari H, Tan TY, Dowzicky MJ. Int J Infect Dis; 2012 Jan; 16(1):e60-6. PubMed ID: 22104303 [Abstract] [Full Text] [Related]
19. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Sader HS, Jones RN, Dowzicky MJ, Fritsche TR. Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565 [Abstract] [Full Text] [Related]
20. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. Nemec A, Krízová L, Maixnerová M, Diancourt L, van der Reijden TJ, Brisse S, van den Broek P, Dijkshoorn L. J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708 [Abstract] [Full Text] [Related] Page: [Next] [New Search]